To this aim , we evaluated the effects of omega-@ PUFA in stable coronary artery disease ( CAD ) patients undergoing percutaneous coronary intervention ( PCI ) on lipoprotein associated phospholipase A@ ( Lp-PLA@ ) mass and activity and their relation to oxidized low-density lipoproteins ( oxy-LDL ) .